Health Hip Clinic, Division of Sports Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Am J Sports Med. 2011 Jul;39 Suppl:14S-9S. doi: 10.1177/0363546511401900.
Femoroacetabular impingement has become more widely recognized in the athletic patient population. The purpose of the present study was to review the clinical outcome after arthroscopic treatment of femoroacetabular impingement in a mixed population of high-level athletes.
Arthroscopic treatment of femoroacetabular impingement results in significant improvement in clinical outcome and a high rate of return to play.
Case series; Level of evidence, 4.
High-level athletes who underwent arthroscopic treatment of femoroacetabular impingement (rim trimming, labral refixation or debridement, femoral osteochondroplasty) with a minimum of 1-year follow-up were retrospectively identified. All patients completed hip-specific outcome scores (Modified Harris Hip Score [MHHS] and Hip Outcome Score [HOS]) at baseline and most recent follow-up.
Forty-seven patients with an average age of 22.8 ± 6.2 years met the study criteria with a mean follow-up of 27.0 ± 5.5 months. Thirty-three patients (70.2%) were available for follow-up. The level of competition was 27.7% varsity high school, 53.2% college, and 19.1% professional athletes. There were statistically significant improvements in the mean MHHS score (preoperative, 68.6 ± 12.8; postoperative, 88.5 ± 17.7; P = .002) as well as the HOS score (preoperative, 78.8 ± 11.3; postoperative, 91.4 ± 14.0; P = .03). There was a significant improvement in the alpha angle, with 76.4° ± 14.5° preoperatively and 51.4° ± 11.7° postoperatively (P = .0003). Seventy-nine percent of patients were able to return to play after hip arthroscopy at a mean of 9.4 ± 4.7 months (range, 4-26 months); of those patients, 92.3% were able to return to the same level of competition. At 2-year follow-up, 73% of patients were able to return to play.
Arthroscopic treatment of femoroacetabular impingement in a mixed group of high-level athletes may result in a significant improvement in hip functional outcome: 78% of athletes were able to return to play at 1 year and 73% of athletes were able to play at 2-year follow-up.
髋关节撞击综合征在运动人群中已得到广泛认识。本研究旨在回顾分析髋关节镜治疗混合高水平运动员髋关节撞击综合征的临床疗效。
髋关节镜治疗髋关节撞击综合征可显著改善临床疗效，且运动员重返赛场的比例较高。
病例系列；证据等级，4 级。
回顾性分析了接受髋关节镜治疗（边缘修整、盂唇修复或清创、股骨骨软骨成形术）且至少随访 1 年的髋关节撞击综合征患者。所有患者均在基线和最近随访时完成髋关节特定的结局评分（改良 Harris 髋关节评分[MHHS]和髋关节结局评分[HOS]）。
47 例患者平均年龄为 22.8 ± 6.2 岁，平均随访 27.0 ± 5.5 个月。33 例（70.2%）患者获得随访。运动水平为：27.7%为高中校队，53.2%为大学，19.1%为职业运动员。MHHS 评分（术前 68.6 ± 12.8，术后 88.5 ± 17.7；P =.002）和 HOS 评分（术前 78.8 ± 11.3，术后 91.4 ± 14.0；P =.03）均有显著改善。α角也有显著改善，术前为 76.4°±14.5°，术后为 51.4°±11.7°（P =.0003）。髋关节镜治疗后，79%的患者能重返赛场，平均时间为 9.4 ± 4.7 个月（4~26 个月）；其中 92.3%的患者能回到原来的运动水平。2 年随访时，73%的患者能重返赛场。
髋关节镜治疗混合高水平运动员髋关节撞击综合征可显著改善髋关节功能：78%的运动员在 1 年时能重返赛场，73%的运动员在 2 年随访时能重返赛场。
